We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Kinetics – Products

Gyrolab® Generic Cyno ADA Kit Reagents
Product News

Gyros Protein Technologies Introduces Gyrolab Generic Cyno ADA Kit Reagents

Gyros Protein Technologies AB has announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.
Streamline Your Metabolite Identification and Clearance Analyses  content piece image
App Note / Case Study

Streamline Your Metabolite Identification and Clearance Analyses

Discover an automated solution for the consolidation and ranking of your metabolite structures. Explore a workflow that utilizes both EAD and CID data for the most confident characterization and streamlined data acquisition.
Identifying Metabolites With Confidence content piece image
App Note / Case Study

Identifying Metabolites With Confidence

Understanding the effects of in vitro drug metabolism is a key aspect of drug discovery and development. However, researchers must be able to make confident decisions quickly and easily.
Reach New Levels of Metabolite Characterization content piece image
App Note / Case Study

Reach New Levels of Metabolite Characterization

Early ADME studies are used to determine if a drug candidate is prone to metabolic breakdown or oxidation/conjugation. Glucuronide conjugation is difficult to characterize using MS/MS alone, therefore fragmentation is also required to obtain structural information.
The Carterra logo
Product News

Carterra Launches the LSAXT High-Throughput SPR Biosensor at SLAS2023

Carterra Inc. launched its latest HT-SPR instrument, the LSAXT, at the Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition in San Diego, CA.
The PhysioMimix™ Single-organ Higher Throughput System
Product News

CN Bio Extends Microphysiological System Portfolio

CN Bio has announced the commercial launch of the PhysioMimix™ Single-organ Higher Throughput System.
A microfluidic system.
Product News

Particle Works Is Optimizing mRNA-LNP Formulation

Particle Works is making major contributions to the field of nanomedicine by producing automated microfluidic systems with the potential to improve efficiency in the nanotherapeutic drug development pipeline.
The insilico medicine logo.
Product News

Insilico Medicine Receives FDA Orphan Drug Designation for INS018_055

Insilico Medicine has announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to INS018_055 for the treatment of idiopathic pulmonary fibrosis.
CN Bio’s PhysioMimix™ Multi-organ microphysiological system
Product News

The FDA Expands Collaboration With CN Bio To Evaluate Multi-Organ Microphysiological System

The U.S. Food and Drug Administration and CN Bio have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ MPS and their applications using the PhysioMimix™ Multi-organ System.
Bioprocessing
Product News

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services

Bruker Corporation and Switzerland-based Biognosys AG have announced a strategic partnership in which Bruker has made a majority-ownership investment in Biognosys.
Advertisement